By  on April 8, 2014

CVS Caremark Corp. has finalized a settlement with the Securities and Exchange Commission that stems from events related to the retailer’s acquisition of Longs Drug Stores in 2008.

The settlement, which was previously announced Aug. 2, 2013, was entered into on a “no-admit-or-deny basis” and will not require CVS to restate its earnings for any reporting period. The company stated that the matter is now fully resolved.

The settlement relates to events that occurred in the third and fourth quarters of 2009, including certain public disclosures made by the company and aspects of the purchase accounting tied to the October 2008 acquisition of Longs.

To Read the Full Article
SUBSCRIBE NOW

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus